National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Trifluridine/tipiracil (Lonsurf®) is indicated for the treatment of adult patients with metastatic colorectal cancer who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-VEGF agents, and anti-EGFR agents.

 

Rapid Review

Commenced Completed Outcome
10/06/2016 11/07/2016 Full Pharmacoeconomic Evaluation Recommended at the Submitted Price